Advanced Enzyme Technologies Limited has completed the acquisition of an additional 1.22% stake in its subsidiary JC Biotech Private Limited (JCB). The transaction involved the purchase of 253,297 equity shares from existing selling shareholders of JCB for a total consideration of ₹22.80 million, at a price of ₹90 per equity share.
This acquisition increases the company's shareholding in JCB from 95.72% to 96.94% of the paid-up share capital of JCB. The transaction became effective from November 18, 2026.
The company is currently in the process of acquiring the remaining 3.06% equity stake in JCB. Upon completion of this additional acquisition, JCB will become a wholly owned subsidiary of Advanced Enzyme Technologies Limited.
This disclosure serves as an update to the company's previous intimation dated August 08, 2026, regarding the acquisition plans.